Latham (SWIM) Reports Earnings Tomorrow: What To Expect
Residential swimming pool manufacturer Latham (NASDAQ:SWIM) will be reporting earnings this Tuesday after market close. Here’s what investors should know.
Latham missed analysts’ revenue expectations last quarter, reporting revenues of $161.9 million, up 7.6% year on year. It was a mixed quarter for the company, with an impressive beat of analysts’ adjusted operating income estimates but a significant miss of analysts’ EPS estimates.
This quarter, the market is expecting Latham’s revenue to grow 9.7% year on year, a reversal from the 4% decrease it recorded in the same quarter last year.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Latham has missed Wall Street’s revenue estimates multiple times over the last two years.
Looking at Latham’s peers in the consumer discretionary - leisure products segment, some have already reported their Q4 results, giving us a hint as to what we can expect. MasterCraft delivered year-on-year revenue growth of 13.2%, beating analysts’ expectations by 4.1%, and Brunswick reported revenues up 15.5%, topping estimates by 10.3%. MasterCraft traded up 8.9% following the results while Brunswick was down 4.7%.
Investors in the consumer discretionary - leisure products segment have had steady hands going into earnings, with share prices flat over the last month. Latham is up 5.8% during the same time and is heading into earnings with an average analyst price target of $7.75 (compared to the current share price of $6.71).
Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we’ve identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Myriad Genetics (MYGN) Shares Rise, Here's the Reason
Ring's Guthrie Incident: Evidence Transmission, Platform Operations, and Market Response
Morgan Stanley's Optimistic Outlook on US Stocks: Examining Flows in the Context of Geopolitical Uncertainty
Rayonier Advanced Materials: Fourth Quarter Earnings Overview
